We Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WE PHARMS, and what generic and branded alternatives to WE PHARMS drugs are available?
WE PHARMS has two approved drugs.
Summary for We Pharms
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for We Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| We Pharms | PREDNISOLONE SODIUM PHOSPHATE | prednisolone sodium phosphate | SOLUTION;ORAL | 075181-001 | Dec 23, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| We Pharms | PREDNISOLONE | prednisolone | SYRUP;ORAL | 040192-001 | May 28, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
